| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2024 | Feb 11, 2025 | Braunstein Scott COB CEO | Buy | Marinus Pharmaceuticals, Inc. | MRNS | $1.1 | $6,526 | +0 |
| Aug 05, 2024 | Aug 07, 2024 | Braunstein Scott COB CEO | Sell | Marinus Pharmaceuticals, Inc. | MRNS | $1.13 | $13,724 | -3.91% |
| Feb 16, 2024 | Feb 21, 2024 | Braunstein Scott COB CEO | Sell | Marinus Pharmaceuticals, Inc. | MRNS | $9.94 | $117,789 | -5.03% |
| Aug 07, 2023 | Aug 09, 2023 | Braunstein Scott COB CEO | Sell | Marinus Pharmaceuticals, Inc. | MRNS | $9.55 | $61,512 | -3.85% |
| Dec 13, 2019 | Dec 13, 2019 | Braunstein Scott CEO | Buy | Marinus Pharmaceuticals Inc | MRNS | $1.25 | $125,000 | +50.00% |
| Jun 05, 2017 | Jun 07, 2017 | Braunstein Scott SVP Strategy Corp. Dev. | Sell | Pacira Pharmaceuticals, Inc. | PCRX | $43.32 | $33,271 | -7.14% |
| Jan 29, 2016 | Feb 02, 2016 | Braunstein Scott SVP Strategy Corp. Dev. | Buy | Pacira Pharmaceuticals, Inc. | PCRX | $58.92 | $117,840 | +50.00% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.